科研之友
微信
新浪微博
Facebook
分享链接
摘要
We and others have recently shown that soyasaponins abundant in soybeans can decrease inflammation by suppressing the nuclear factor kappa B (NF-kB)-mediated inflammation. However, the exact molecular mechanisms by which soyasaponins inhibit the NF-kB pathway have not been established. In this study in macrophages, soyasaponins (A(1), A(2) and I) inhibited the lipopolysaccharide (LPS)-induced release of inflammatory marker prostaglandin E-2 (PGE(2)) to a similar extent as the NF-kB inhibitor (BAY117082). Soyasaponins (A(1), A(2) and I) also suppressed the LPS-induced expression of cyclooxygenase 2 (COX-2), another inflammatory marker, in a dose-dependent manner by inhibiting NF-kB activation. In defining the associated mechanisms, we found that soyasaponins (A(1), A(2) and I) blunted the LPS-induced IKK alpha/beta phosphorylation, IkB phosphorylation and degradation, and NF-kB p65 phosphorylation and nuclear translocation. In studying the upstream targets of soyasaponins on the NF-kB pathway, we found that soyasaponins (A(1), A(2) and I) suppressed the LPS-induced activation of PI3K/Akt similarly as the PI3K inhibitor LY294002, which alone blocked the LPS-induced activation of NF-kB. Additionally, soyasaponins (A(1), A(2) and I) reduced the LPS-induced production of reactive oxygen species (ROS) to the same extent as the anti-oxidant N-acetyl-L-cysteine, which alone inhibited the LPS-induced phosphorylation of Akt, IKK alpha/beta, IkB alpha, and p65, transactivity of NF-kB, PGE2 production, and malondialdehyde production. Finally, our results show that soyasaponins (A(1), A(2) and I) elevated SOD activity and the GSH/GSSG ratio. Together, these results show that soyasaponins (A(1), A(2) and I) can blunt inflammation by inhibiting the ROS-mediated activation of the PI3K/Akt/NF-kB pathway.
